Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.53 |
| ▸ | MCHR1 | Q99705 | 15/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 11/20 | 0.46 |
| ▸ | HRH1 | P35367 | 4/20 | 0.46 |
| ▸ | HTR2B | P41595 | 4/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6879285 | 1.00 | EPHX1 (0.53) | EPHX1MCHR1ADRA2AHRH1HTR2B | |
| SCHEMBL6869351 | 0.93 | EPHX1 (0.46) | EPHX1MCHR1ADRA2AHRH1HTR2B | |
| SCHEMBL6869347 | 0.93 | EPHX1 (0.46) | EPHX1MCHR1ADRA2AHRH1HTR2B | |
| SCHEMBL6462540 | 0.93 | EPHX1 (0.45) | EPHX1MCHR1ADRA2AHRH1HTR2B | |
| SCHEMBL6462544 | 0.93 | EPHX1 (0.45) | EPHX1MCHR1ADRA2AHRH1HTR2B | |
| SCHEMBL6464453 | 0.92 | EPHX1 (0.44) | EPHX1MCHR1ADRA2AHRH1HTR2B | |
| SCHEMBL6464449 | 0.92 | EPHX1 (0.44) | EPHX1MCHR1ADRA2AHRH1HTR2B | |
| SCHEMBL6464301 | 0.92 | EPHX1 (0.44) | EPHX1MCHR1ADRA2AHRH1HTR2B | |
| SCHEMBL6464294 | 0.92 | EPHX1 (0.44) | EPHX1MCHR1ADRA2AHRH1HTR2B | |
| SCHEMBL6876661 | 0.90 | MCHR1 (0.44) | EPHX1MCHR1ADRA2AHRH1HTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1464335-A2 | Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist | Taisho Pharmaceutical Co. Ltd. (JP) | 2004-10-06 | — | — | EP | disclosed |